Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Brain Diseases

• Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia
• Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
• Ketamine in Severe Traumatic Brain Injury
• Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
• Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
• RESTORE: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
• Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
• A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies
• SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
• Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
• The Efficacy and Safety of Rifaximin Treatment
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
• Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy
• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
• A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
• Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
• PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
• Neonatal Brain Ultrasound With CEUS and Elastography
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
• MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial
• A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
• A Phase I Safety and Feasibility of Metformin Treatment in Infants After Perinatal Brain Injury
• Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy
• A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
• An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
• A Multicenter, Randomized Trial to Assess Safety, and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
• Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
• Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
• Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer
• Propranolol on Post Stroke Immune Status and Infection
• Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
• Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
• Study to Assess the Efficacy of XPro™ in Patients With Mild Alzheimer's Disease With Biomarkers of Inflammation
• Extension Study to Evaluate NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
• PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
• CaffeinICU Study - A Pilot Study on the Efficacy of Oral Caffeine in Reducing the Duration of Mechanical Ventilation
• Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
• Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Subjects With SCN8A-DEE.
• Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
• Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy
• Efficacy of Erenumab in Chronic Cluster Headache
• Dopaminergic Therapy for Frontotemporal Dementia Patients
• Phenylbutyrate for STXBP1 Encephalopathy and SLC6A1 Neurodevelopmental Disorder
• An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
• VE303 for Treatment of Hepatic Encephalopathy (HE)
• Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
• Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease
• TReatment for ImmUne Mediated PathopHysiology
• Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
• Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
• Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
• SGM-101 in Colorectal Brain Metastases.
• Microbial Resistance of Rifaximin in Hepatic Encephalopathy
• Beneficial Effect of Intravenous Magnesium Sulphate in Term Neonates With Hypoxic Ischemic Encephalopathy(HIE)
• NVD in Hypothermic HIE Neonates
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
• XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
• Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
• Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)
• Erythropoietin and Darbepoetin in Neonatal Encephalopathy Trial
• Metabolic and Hemodynamic Reserve in Pediatric SCA
• PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
• Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients
• A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
• The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients
• Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
• Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
• A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
• Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
• MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
• Rifamycin in Minimal Hepatic Encephalopathy
• Adjunctive Sedation With Dexmedetomidine for the Prevention of Severe Inflammation and Septic Encephalopathy
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
• PEG3350 in ACLF With Hepatic Encephalopathy
• Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
• Caffeine for Hypoxic-Ischemic Encephalopathy
• FMT in Cirrhosis and Hepatic Encephalopathy
• Memantine for Epileptic Encephalopathy
• Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
• BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
• CEUS Evaluation of Hypoxic Ischemic Injury
• Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
• Alcohol: Thiamine and or Magnesium 1
• To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.
• Fluoxetine Opens Window to Improve Motor Recovery After Stroke
• Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
• To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
• Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
• The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
• Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy
• Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
• Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
• Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome
• To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
• Oral Fecal Transplant in Cirrhosis
• EEG Cap for Identification of Non-Convulsive Status Epilepticus
• High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.
• PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
• PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns
• Mild Encephalopathy in the Newborn Treated With Darbepoetin
• Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
• Cannabidiol in Children With Refractory Epileptic Encephalopathy
• Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
• Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
• Sildenafil Administration to Treat Neonatal Encephalopathy
• High-dose Erythropoietin for Asphyxia and Encephalopathy
• Lipolytic Effects of GH in Hypopituitary Patients in Vivo
• Dexmedetomidine Verses Propofol for Paediatric MRI Brain
• Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns
• Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
• General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
• Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
• Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)
• Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy
• Erythropoietin in Premature Infants to Prevent Encephalopathy
• Dexmedetomidine Pharmacokinetics in Neonates During Therapeutic Hypothermia
• Metformin Experience on Minimal Hepatic Encephalopathy
• Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
• Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)
• Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
• Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy
• Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
• The Effects of Nitazoxanide in Hepatic Encephalopathy
• Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.
• Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
• B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study.
• MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
• Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy
• Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
• A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
• 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
• Crossover Comparison of MultiHance and Dotarem
• TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation
• NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy
• Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
• Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.
• Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):
• Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
• Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients
• Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
• Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
• Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
• Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
• Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
• Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
• Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
• Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
• The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy
• Quality of Life and Nutritional Improvements in Cirrhotic Patients
• Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
• Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy
• Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
• L-ornithine L-aspartate in Overt Hepatic Encephalopathy
• Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic Encephalopathy
• Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
• Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
• Effect of Tolvaptan on Cognitive Function in Cirrhosis
• Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth
• Darbe Administration in Newborns Undergoing Cooling for Encephalopathy
• S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE
• Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics
• Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
• Safety and Efficacy of Topiramate in Neonates With Hypoxic Ischemic Encephalopathy Treated With Hypothermia
• Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
• Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
• Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
• Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
• Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
• Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
• Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
• Sedation to Electroencephalography With Dexmedetomidine or Chloral Hydrate
• Study of Rifaximin in Minimal Hepatic Encephalopathy
• Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy
• Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
• Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
• Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
• A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group
• Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
• A Study of Controlled Lactulose Withdrawal
• Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
• Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
• Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
• Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
• AST-120 Used to Treat Mild Hepatic Encephalopathy
• Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
• Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation
• Study of Lactulose in Children With Chronic Liver Disease
• Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
• Septic Encephalopathy and Late Cognitive Dysfunction
• Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy
• Neonatal Erythropoietin in Asphyxiated Term Newborns
• Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy
• A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
• Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy
• Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
• Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
• Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
• Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
• Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
• Rifaximin in Minimal Hepatic Encephalopathy
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
• Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
• Dyskinesia in Parkinson's Disease (Study P04501)
• Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
• RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
• Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.
• A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
• Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
• N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
• A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
• Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
• A Study of Azidothymidine in HIV-Infected Children
• A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.